Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells

被引：21
|
作者：
Jiang, Hua [1 ]
Song, Bo [2 ]
Wang, Peng [2 ]
Shi, Bizhi [1 ]
Li, Qixiang [3 ]
Fan, Mingliang [1 ]
Di, Shengmeng [1 ]
Yang, Jie [4 ]
Li, Zonghai [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200032, Peoples R China
[2] CARsgen Therapeut, Shanghai 200231, Peoples R China
[3] Crown Biosci Inc, Sci Technol Innovat Pk, Taicang City 215400, Peoples R China
[4] Shanghai Blood Ctr, Blood Engn Lab, Shanghai 200051, Peoples R China
来源：
PROTEIN & CELL | 2017年 / 8卷 / 12期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1007/s13238-017-0472-9
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：926 / 931
页数：6
相关论文
共 50 条
  • [41] Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model
    Yuki Fujii
    Hirofumi Kamachi
    Fumihiko Matsuzawa
    Tatsuzo Mizukami
    Nozomi Kobayashi
    Moto Fukai
    Akinobu Taketomi
    [J]. Investigational New Drugs, 2021, 39 : 1256 - 1266
  • [42] Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models
    Yuan, Yuncang
    Fan, Jiawei
    Liang, Dandan
    Wang, Shijie
    Luo, Xu
    Zhu, Yongjie
    Liu, Nan
    Xiang, Tingxiu
    Zhao, Xudong
    [J]. TRANSLATIONAL ONCOLOGY, 2024, 39
  • [43] HUMAN BINDING DOMAINS REDUCE NEUROTOXICITY OF ANTI-CD19 CAR-T CELLS
    不详
    [J]. CANCER DISCOVERY, 2020, 10 (03) : 338 - 338
  • [44] Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells
    Tanyi, Janos L.
    Stashwick, Caitlin
    Plesa, Gabriela
    Morgan, Mark A.
    Porter, David
    Maus, Marcela V.
    June, Carl H.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2017, 40 (03) : 104 - 107
  • [45] CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
    Zhu, Hongjia
    Fang, Xiaoyan
    Tuhin, Israth Jahan
    Tan, Jingwen
    Ye, Jing
    Jia, Yujie
    Xu, Nan
    Kang, Liqing
    Li, Minghao
    Lou, XiaoYan
    Zhou, Jing-E
    Wang, Yiting
    Yan, Zhiqiang
    Yu, Lei
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (09) : 2261 - 2274
  • [46] CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
    Hongjia Zhu
    Xiaoyan Fang
    Israth Jahan Tuhin
    Jingwen Tan
    Jing Ye
    Yujie Jia
    Nan Xu
    Liqing Kang
    Minghao Li
    XiaoYan Lou
    Jing-e Zhou
    Yiting Wang
    Zhiqiang Yan
    Lei Yu
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2261 - 2274
  • [47] Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
    Wehrli, Marc
    Guinn, Samantha
    Birocchi, Filippo
    Kuo, Adam
    Sun, Yi
    Larson, Rebecca C.
    Almazan, Antonio J.
    Scarfo, Irene
    Bouffard, Amanda A.
    Bailey, Stefanie R.
    Anekal, Praju Vikas
    Montero Llopis, Paula
    Nieman, Linda T.
    Song, Yuhui
    Xu, Katherine H.
    Berger, Trisha R.
    Kann, Michael C.
    Leick, Mark B.
    Silva, Harrison
    Salas-Benito, Diego
    Kienka, Tamina
    Grauwet, Korneel
    Armstrong, Todd D.
    Zhang, Rui
    Zhu, Qingfeng
    Fu, Juan
    Schmidts, Andrea
    Korell, Felix
    Jan, Max
    Choi, Bryan D.
    Liss, Andrew S.
    Boland, Genevieve M.
    Ting, David T.
    Burkhart, Richard A.
    Jenkins, Russell W.
    Zheng, Lei
    Jaffee, Elizabeth M.
    Zimmerman, Jacquelyn W.
    Maus, Marcela V.
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (09) : 1859 - 1877
  • [48] Efficient generation of locus-specific human CAR-T cells with CRISPR/cCas12a
    Ling, Xinyu
    Chang, Liying
    Chen, Heqi
    Liu, Tao
    [J]. STAR PROTOCOLS, 2022, 3 (02):
  • [49] First-in-human anti-ALPP CAR-T cell immunotherapy for ovarian and endometrial cancer
    Zhu, B.
    Jia, Q.
    Chen, R.
    Chen, G.
    Zhao, L.
    Palmer, N.
    Xiang, D.
    Chen, F.
    Duan, Y.
    Wang, H.
    Shan, J.
    Xiong, L.
    Xie, R.
    Li, G.
    Yan, L.
    Li, R.
    Xia, L.
    Su, Z.
    Alexander, P.
    Li, S.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S807 - S807
  • [50] AUTOLOGOUS ANTI-GD2 CAR-T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA
    Chiavelli, C.
    Rovesti, G.
    Prapa, M.
    Neri, G.
    Pugliese, G.
    Trudu, L.
    Silingardi, M.
    Dall'Ora, M.
    Golinelli, G.
    Grisendi, G.
    Bestagno, M.
    Spano, C.
    Papapietro, R. V.
    Depenni, R.
    Di Emidio, K.
    Pasetto, A.
    Silva, D. Nascimento
    Feletti, A.
    Berlucchi, S.
    Iaccarino, C.
    Pavesi, G.
    Dominici, M.
    [J]. HUMAN GENE THERAPY, 2023, 34 (21-22) : A42 - A43
12345